↓ Skip to main content

Cochrane Database of Systematic Reviews

Naftidrofuryl for intermittent claudication

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
217 Mendeley
Title
Naftidrofuryl for intermittent claudication
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd001368.pub4
Pubmed ID
Authors

Tine LM de Backer, Robert Vander Stichele, Philippe Lehert, Luc Van Bortel

Abstract

Lifestyle changes and cardiovascular prevention measures are a primary treatment for intermittent claudication (IC). Symptomatic treatment with vasoactive agents (Anatomic Therapeutic Chemical Classification (ATC) for medicines from the World Health Organisation class CO4A) is controversial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 216 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 35 16%
Student > Bachelor 24 11%
Researcher 21 10%
Student > Ph. D. Student 19 9%
Other 11 5%
Other 31 14%
Unknown 76 35%
Readers by discipline Count As %
Medicine and Dentistry 70 32%
Nursing and Health Professions 19 9%
Psychology 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Sports and Recreations 7 3%
Other 21 10%
Unknown 81 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2020.
All research outputs
#6,712,226
of 24,755,976 outputs
Outputs from Cochrane database of systematic reviews
#8,415
of 12,968 outputs
Outputs of similar age
#66,841
of 289,685 outputs
Outputs of similar age from Cochrane database of systematic reviews
#111
of 197 outputs
Altmetric has tracked 24,755,976 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,968 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,685 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.